Articularis Rheumatology Network

The ARN-Trio registry recently hosted a webinar unlocking deep insights into the “Why” behind patients discontinuing prescription therapy. The recorded webinar is available here. ARN-Trio registry uniquely employs trained chart abstractors to review unstructured data for the 369,000 patients in the registry, identifying the actual reasons for discontinuations as recorded in the visit notes. Traditionally, …

Why do Patients Discontinue Treatment? Read More »

Analysis of the American Rheumatology Network-Trio Health (ARN-Trio) registry finds a surge in new prescriptions for Merck’s Renflexis infliximab biosimilar. The ARN-Trio registry is the first rheumatology registry to combine pharmacy dispensing data with electronic medical records (EMR) to provide unparalleled real-world insights. ARN-Trio is the largest registry of biosimilar use in community rheumatology practice, …

ARN-Trio Registry Highlights Major Shifts in Infliximab Biosimilar Use Read More »

We are excited to announce that we are providing all American Rheumatology Network (ARN) physicians with a group membership in the American Medical Association (AMA), which offers unique benefits tailored to the needs of our large medical practice. What this means for you Your membership is sponsored by American Rheumatology Network at no cost to …

American Rheumatology Network Announces Partnership with AMA Read More »

Analysis of the American Rheumatology Network-Trio Health (ARN-Trio) registry finds that AbbVie’s Rinvoq use is increasing rapidly as a proportion of JAK inhibitor use. Rheumatologists are asking, why is use of AbbVie’s Rinvoq increasing so rapidly? Given the higher cost of Rinvoq (annual net price $44,035) and similar safety and efficacy across the JAK inhibitor …

Formulary Exclusions Favor Rinvoq Use and Increase Costs Read More »

American Rheumatology Network (ARN) and Trio Health (Trio) have launched the first rheumatology registry that combines pharmacy dispensing data with electronic medical records (EMR) to provide unparalleled real-world insights into patient experiences and outcomes. The new database includes over 75,000 patients within the ARN’s national network, serving as a comprehensive data solution that combines EMR, …

Join the ARN-Trio Health Registry, Inform Your Clinical Care and Generate Additional Revenue Read More »

The American Rheumatology Network (ARN) has been so successful with cost management, particularly via the use of biosimilars, that it believes its model is worthy of emulation, said Colin C. Edgerton, MD, executive chairman of ARN, who spoke on the subject recently in an Academy of Managed Care Pharmacy–sponsored webinar. “Certainly, rheumatologists are eager to …

ARN Physician Featured in: American Rheumatology Network Promotes a Biosimilar Pathway Read More »

by Colin Edgerton We are seeing COVID-19 cases peak in many areas of the US, prompting thoughts about what comes next for rheumatology practices. Many community rheumatology practices have been hit hard by the crisis, and we hope that sharing “lessons learned” will inform practices on what steps to take now, and what to anticipate …

Weathering the Storm: A Successful Rheumatology Practice During the COVID Crisis Read More »

As of 12:30pm ET on March 17, 2020 CMS has sent out an official notification stating that effective for services starting March 6, 2020 (retroactive), the limitations on where Medicare patients are eligible for telehealth services has been removed during the emergency. The waiver temporarily eliminates the requirement that the originating site must be a …

American Rheumatology Network Telehealth Payer Update: COVID-19 Read More »

The American Rheumatology Network (ARN) continues to monitor federal, state and local health advisories regarding the coronavirus (COVID-19) and will update this resource accordingly.  Please note this document contains general information which may not be applicable to all patients, facilities, communities and circumstances. This resource guide is intended to provide you with suggestions on how …

A Resource for Independent Rheumatology Clinics: COVID-19 Read More »

Updated March 17, 2020 3:00pm American Rheumatology Network (ARN) members are concerned about safe access to care during the COVID-19 pandemic. The Centers for Disease Control and Prevention (CDC) has recommended use of telehealth, when clinically appropriate, to lessen the risk of disease transmission. CDC recommendations are fluid and rapidly changing, and rheumatologists and rheumatology …

American Rheumatology Telehealth Overview: Caring for Patients during the COVID-19 Pandemic Read More »